Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion type Assertion NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_head.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion description "[Furthermore, PDGFRA and HRAS mRNA levels were significantly associated with tumor aggressiveness in lymph node-negative patients who had not received adjuvant systemic therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_provenance.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion evidence source_evidence_literature NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_provenance.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion SIO_000772 19966015 NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_provenance.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion wasDerivedFrom befree-20140225 NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_provenance.
- NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_assertion wasGeneratedBy ECO_0000203 NP346524.RA3YtxcO3WnXHIMQecdPR7jjm6HbX6BnEw3wB0gD5gxO8130_provenance.